Alternative names : Oxandrolone, Oxandrin
Packaging : 100tabs/bottle 10mg/tab.
Dosage: 20mg - 50mg / day
Oxandrin (Oxandrolone) oral tablets contain 2.5 mg or 10 mg of the anabolic steroid Oxandrolone.
Oxandrolone is 17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one with the following structural formula:
Oxandrin® (Oxandrolone) Structural Formula Illustration
Inactive ingredients include cornstarch, lactose, magnesium stearate, and hydroxypropyl methylcellulose.
Side effects :
Patients with moderate to severe COPD or COPD patients who are unresponsive to bronchodilators should be monitored closely for COPD exacerbation and fluid retention. The following adverse reactions have been associated with use of anabolic steroids: Hepatic: Cholestatic jaundice with, rarely, hepatic necrosis and death. Hepatocellular neoplasms and peliosis hepatis with long-term therapy (See WARNINGS). Reversible changes in liver function tests also occur including increased bromsulfophthalein (BSP) retention, changes in alkaline phosphatase and increases in serum bilirubin, aspartate aminotransferase (AST, SGOT) and alanine aminotransferase (ALT, SGPT) In males Prepubertal: Phallic enlargement and increased frequency or persistence of erections. Postpuberal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis, and bladder irritability. In females Clitoral enlargement, menstrual irregularities. CNS: Habituation, excitation, insomnia, depression, and changes in libido. Hematologic: Bleeding in patients on concomitant oral anticoagulant therapy. Breast: Gynecomastia. Larynx: Deepening of the voice in females. Hair:Hirsutism and male pattern baldness in females. Skin:Acne (especially in females and prepubertal males). Skeletal: Premature closure of epiphyses in children (See PRECAUTIONS: Pediatric use). Fluid and electrolytes: Edema, retention of serum electrolytes (sodium chloride, potassium, phosphate, calcium). Metabolic/Endocrine: Decreased glucose tolerance (See PRECAUTIONS: Laboratory tests), increased creatinine excretion, increased serum levels of creatinine phosphokinase (CPK). Masculinization of the fetus. Inhibition of gonadotropin secretion. Drug Abuse And Dependence Oxandrolone is classified as a controlled substance under the Anabolic Steroids Control Act of 1990 and has been assigned to Schedule III (non-narcotic).
Check out our complete list of ORAL STEROIDS